US2016354425A1PendingUtilityA1

Methods for treating hcv

50
Assignee: GILEAD PHARMASSET LLCPriority: Sep 16, 2011Filed: Jun 13, 2016Published: Dec 8, 2016
Est. expirySep 16, 2031(~5.2 yrs left)· nominal 20-yr term from priority
Inventors:William E. Delaney, IvJohn O. LinkHongmei MoDavid W. OldachAdrian S. RayWilliam J. WatkinsCheng Yong Yang
A61P 31/14A61P 31/12A61P 31/00A61P 43/00A61P 31/22A61P 1/16A61K 31/7056A61K 38/212A61K 31/4196A61K 45/06A61K 31/4184A61K 9/0053A61K 31/7072A61K 31/513A61K 31/7052A61K 9/20A61K 31/381A61K 38/06A61K 2300/00
50
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

This invention relates to combinations of therapeutic molecules useful for treating hepatitis C virus infection. The present invention relates to methods, uses, dosing regimens, and compositions.

Claims

exact text as granted — not AI-modified
1 . A composition comprising:
 compound 3 having the structure:   
       
         
           
           
               
               
           
         
         or a pharmaceutically acceptable salt thereof; and 
         compound 6 having the structure: 
       
       
         
           
           
               
               
           
         
         or a pharmaceutically acceptable salt thereof. 
       
     
     
         2 . The composition of  claim 1 , further comprising one or more pharmaceutically acceptable diluents or carriers. 
     
     
         3 . The composition of  claim 1 , which is formulated as a unit dosage form for once daily administration. 
     
     
         4 . The composition of  claim 3 , which is formulated for oral administration. 
     
     
         5 . The composition of  claim 4 , which is formulated as a tablet. 
     
     
         6 . The composition of  claim 1 , further comprising ribavirin.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.